Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer

Artificial Mini Dendritic Cells Boost T Cell–Based Immunotherapy for Ovarian Cancer

Abstract Ovarian cancer is the most lethal gynecological malignancy with high recurrence rates and low survival rates, remaining a disease of high unmet need. Cancer immunotherapy, which harnesses the potential of the immune system to attack tumors, has emerged as one of the most promising treatment...

Full description

Bibliographic Details
Main Authors: Shanshan Cheng, Cong Xu, Yue Jin, Yu Li, Cheng Zhong, Jun Ma, Jiani Yang, Nan Zhang, Yuan Li, Chao Wang, Zhiyou Yang, Yu Wang
Format: Article
Language:English
Published: Wiley 2020-04-01
Series:Advanced Science
Subjects:
dendritic cells
immunotherapy
nanovaccines
ovarian cancer
T cells
Online Access:https://doi.org/10.1002/advs.201903301

Internet

https://doi.org/10.1002/advs.201903301

Similar Items